HLS Therapeutics Inc. (TSX:HLS)
3.670
-0.090 (-2.39%)
Nov 19, 2026, 4:00 PM EST
HLS Therapeutics Revenue
HLS Therapeutics had revenue of $14.16M USD in the quarter ending September 30, 2026, with 4.77% growth. This brings the company's total for the last twelve months to $56.89M, up 1.86% year-over-year. In the year 2025, HLS Therapeutics had annual revenue of $55.50M, down -1.98%. That makes HLS Therapeutics the 27,147th largest company in the world by revenue and 491st in Canada.
Revenue (ttm)
$56.89M
Revenue Growth
+1.86%
P/S Ratio
1.42
Revenue / Employee
$669.26K
Employees
85
Market Cap
111.72M CAD
Revenue by Geography
- Canada 42.47M 76.5%
- United States 12.56M 22.6%
- Rest of World 478.00K 0.9%
Fiscal year ended Dec 31, 2025 See the full HLS Therapeutics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 55.50M | -1.12M | -1.98% |
| Dec 31, 2024 | 56.62M | -6.46M | -10.23% |
| Dec 31, 2023 | 63.07M | 1.61M | 2.61% |
| Dec 31, 2022 | 61.47M | 1.46M | 2.43% |
| Dec 31, 2021 | 60.01M | 3.90M | 6.95% |
| Dec 31, 2020 | 56.11M | 1.95M | 3.60% |
| Dec 31, 2019 | 54.16M | -7.26M | -11.81% |
| Dec 31, 2018 | 61.42M | -13.67M | -18.20% |
| Dec 31, 2017 | 75.08M | 21.05M | 38.96% |
| Dec 31, 2016 | 54.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ascend Wellness Holdings | 700.76M |
| TerrAscend | 379.07M |
| Organigram Global | 309.18M |
| Medexus Pharmaceuticals | 152.84M |
| Decibel Cannabis Company | 127.08M |
| Cannara Biotech | 117.33M |
| Charlotte's Web Holdings | 63.51M |
| Grown Rogue International | 57.07M |
HLS Therapeutics News
- 7 days ago - HLS Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 7 days ago - HLS Therapeutics Earnings release: Q3 2026 - Filings
- 7 days ago - HLS Therapeutics Report: Q3 2026 - Filings
- 7 days ago - HLS Therapeutics MD&A: Q3 2026 - Filings
- 7 days ago - HLS Therapeutics Slides: Q3 2026 - Filings
- 22 days ago - HLS Therapeutics Transcript: Planet MicroCap Showcase: Toronto 2026 - Transcripts
- 6 weeks ago - HLS Therapeutics Slides: Investor presentation - Filings
- 6 weeks ago - HLS Therapeutics Slides: Corporate presentation - Filings